<--- Back to Details
First PageDocument Content
Antibiotics / Bacterial diseases / Staphylococcaceae / Microbiology / Clindamycin / Lincosamides / Antibiotic resistance / Staphylococcus aureus / Linezolid / Chemistry / Bacteria / Medicine
Date: 2010-02-25 08:20:22
Antibiotics
Bacterial diseases
Staphylococcaceae
Microbiology
Clindamycin
Lincosamides
Antibiotic resistance
Staphylococcus aureus
Linezolid
Chemistry
Bacteria
Medicine

Add to Reading List

Source URL: journals.lww.com

Download Document from Source Website

File Size: 357,79 KB

Share Document on Facebook

Similar Documents

Sales of different classes of antibiotics to outpatients 1997 in the EU Cars O, Mölstad S, Melander A, Lancet 357;9271:others macrolides and lincosamides J01F

DocID: 1fDoE - View Document

Science / Antibiotics / Chromatography / Ionophore / Lincosamides / Antibiotic resistance / Quinolone / Mass spectrometry / Oxytetracycline / Chemistry / Scientific method / Chemical pathology

Analysis of antibiotics in feedingstuffs by liquid chromatography and tandem mass spectrometry (LC-MS/MS) Cédric Guignard, Emmanuelle Cocco, Torsten Bohn and Lucien Hoffmann

DocID: PLjM - View Document

Eli Lilly and Company / Organic chemistry / Medicine / Beta-lactam antibiotics / Microbiology / Cephalosporin / Quinolone / Lincosamides / Macrolide / Antibiotics / Chemistry / Piperazines

Mike Apley Kansas State University 2003 - Daptomycin – cyclic lipopeptides[removed]Linezolid - oxazolidinones 1985 – Imipenem - carbapenems

DocID: LTGe - View Document

Medicine / Health / Lincosamides / Antimicrobial / Enterococcus faecalis / Streptogramin / Antibiotic resistance / Aminoglycoside / Antibiotics / Microbiology / Biology

Figure 5d. Antimicrobial Resistance among Enterococcus from Pork Chops, [removed]% 90% 80% % Resistance

DocID: BtbJ - View Document

Biology / The People of Freedom / Lincosamides / Helicobacter pylori

July 1, 2014: Preferred Drug List (PDL) Changes Effective[removed]Changes to the Medicaid Preferred Drug List (PDL) approved following the January and April 2014 Pharmaceutical & Therapeutics (P&T) Committee meetings w

DocID: AwZE - View Document